Dr. Mileham Discusses Biomarkers in Lung Cancer
Kathryn Mileham, MD, medical oncologist, Levine Cancer Institute, Carolinas HealthCare System, discusses biomarkers in lung cancer.
The landscape of lung cancer has changed tremendously over the past 20 years, says Mileham. With the discovery of numerous mutations, the development of biomarkers and biomarker testing has blossomed.
Mileham says that the established biomarkers that are predictive in response for non–small cell lung cancer are ALK, ROS1, EGFR, BRAF, and PD-L1.